CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?

Am J Hematol. 2002 Oct;71(2):139. doi: 10.1002/ajh.10187.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / chemically induced*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology
  • Lymphoma / drug therapy
  • Lymphoma / pathology*
  • Male
  • Neoplasms, Second Primary / chemically induced
  • Neoplasms, Second Primary / etiology
  • Time Factors
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use

Substances

  • Antineoplastic Agents
  • Vidarabine
  • fludarabine